APP and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative condition resulting in part from increased β-secretase cleavage of amyloid precursor protein (APP) and a concomitant increase in amyloid-β (Aβ) over the alternative α-secretase cleavage products [1, 2].